Commonwealth Equity Services
ABBV icon

Commonwealth Equity Services’s AbbVie ABBV Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$224M Sell
1,204,834
-58,806
-5% -$10.9M 0.3% 63
2025
Q1
$265M Buy
1,263,640
+40,114
+3% +$8.4M 0.37% 48
2024
Q4
$217M Sell
1,223,526
-557
-0% -$99K 0.32% 57
2024
Q3
$242M Sell
1,224,083
-10,296
-0.8% -$2.03M 0.37% 47
2024
Q2
$212M Buy
1,234,379
+19,662
+2% +$3.37M 0.34% 51
2024
Q1
$221M Buy
1,214,717
+20,070
+2% +$3.65M 0.37% 46
2023
Q4
$185M Sell
1,194,647
-18,290
-2% -$2.83M 0.34% 52
2023
Q3
$181M Sell
1,212,937
-9,040
-0.7% -$1.35M 0.37% 46
2023
Q2
$165M Sell
1,221,977
-41,680
-3% -$5.62M 0.33% 54
2023
Q1
$201K Sell
1,263,657
-16,342
-1% -$2.6K 0.42% 38
2022
Q4
$207M Buy
1,279,999
+4,608
+0.4% +$745K 0.5% 34
2022
Q3
$171M Sell
1,275,391
-20,447
-2% -$2.74M 0.44% 39
2022
Q2
$198M Buy
1,295,838
+1,260
+0.1% +$193K 0.52% 32
2022
Q1
$210M Buy
1,294,578
+6,377
+0.5% +$1.03M 0.48% 34
2021
Q4
$174M Buy
1,288,201
+67,815
+6% +$9.18M 0.39% 46
2021
Q3
$132M Buy
1,220,386
+42,153
+4% +$4.55M 0.33% 61
2021
Q2
$133M Buy
1,178,233
+21,907
+2% +$2.47M 0.34% 59
2021
Q1
$125M Buy
1,156,326
+30,317
+3% +$3.28M 0.35% 55
2020
Q4
$121M Buy
1,126,009
+88,816
+9% +$9.52M 0.36% 54
2020
Q3
$90.8M Buy
1,037,193
+41,664
+4% +$3.65M 0.31% 68
2020
Q2
$97.7M Buy
995,529
+120,912
+14% +$11.9M 0.37% 56
2020
Q1
$66.6M Buy
874,617
+41,338
+5% +$3.15M 0.31% 68
2019
Q4
$73.8M Buy
833,279
+19,715
+2% +$1.75M 0.28% 73
2019
Q3
$61.6M Sell
813,564
-82,010
-9% -$6.21M 0.26% 77
2019
Q2
$65.1M Buy
895,574
+15,287
+2% +$1.11M 0.29% 75
2019
Q1
$70.9M Buy
880,287
+34,533
+4% +$2.78M 0.33% 70
2018
Q4
$78M Buy
845,754
+58,391
+7% +$5.38M 0.41% 52
2018
Q3
$74.5M Buy
787,363
+2,245
+0.3% +$212K 0.36% 60
2018
Q2
$72.7M Buy
785,118
+29,343
+4% +$2.72M 0.38% 56
2018
Q1
$71.5M Buy
755,775
+16,120
+2% +$1.53M 0.39% 57
2017
Q4
$71.5M Buy
739,655
+104,967
+17% +$10.2M 0.39% 57
2017
Q3
$56.4M Buy
634,688
+11,070
+2% +$984K 0.34% 69
2017
Q2
$45.2M Buy
623,618
+1,378
+0.2% +$99.9K 0.29% 79
2017
Q1
$40.5M Buy
622,240
+22,559
+4% +$1.47M 0.27% 82
2016
Q4
$37.6M Buy
599,681
+12,488
+2% +$782K 0.28% 76
2016
Q3
$37M Buy
587,193
+14,166
+2% +$893K 0.29% 71
2016
Q2
$35.5M Buy
573,027
+15,760
+3% +$976K 0.3% 73
2016
Q1
$31.8M Buy
557,267
+66,017
+13% +$3.77M 0.28% 73
2015
Q4
$29.1M Buy
491,250
+70,282
+17% +$4.16M 0.28% 75
2015
Q3
$22.9M Buy
420,968
+7,506
+2% +$408K 0.24% 87
2015
Q2
$27.8M Buy
413,462
+919
+0.2% +$61.7K 0.28% 71
2015
Q1
$24.2M Buy
412,543
+53,976
+15% +$3.16M 0.25% 81
2014
Q4
$23.5M Buy
358,567
+7,045
+2% +$461K 0.26% 76
2014
Q3
$20.3M Buy
351,522
+17,979
+5% +$1.04M 0.25% 80
2014
Q2
$18.8M Buy
333,543
+1,907
+0.6% +$108K 0.23% 91
2014
Q1
$17M Buy
331,636
+10,923
+3% +$561K 0.24% 87
2013
Q4
$16.9M Buy
320,713
+21,726
+7% +$1.15M 0.25% 85
2013
Q3
$13.4M Buy
298,987
+20,550
+7% +$919K 0.22% 102
2013
Q2
$11.5M Buy
+278,437
New +$11.5M 0.2% 108